Clinical Trial Update: VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial) [NA]

View source ↗

Summary

This document announces a TRIVITA pivotal trial evaluating a VDyne transcatheter tricuspid valve replacement for symptomatic severe tricuspid regurgitation and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Valve Disease
• Tricuspid Valve Regurgitation

Drugs mentioned

• VDyne Transcatheter Tricuspid Valve Replacement

Snippet

Sponsor: VDyne, Inc. | Conditions: Tricuspid Valve Regurgitation, Tricuspid Valve Disease | NA | Status: NOT_YET_RECRUITING